These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7092578)

  • 1. The effect of diet on the transport of probucol in monkeys.
    Eder HA
    Artery; 1982; 10(2):105-7. PubMed ID: 7092578
    [No Abstract]   [Full Text] [Related]  

  • 2. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it harmful to lower HDL levels?
    Henahan J
    JAMA; 1981 Nov; 246(20):2311, 2315. PubMed ID: 7299948
    [No Abstract]   [Full Text] [Related]  

  • 5. [How do changes in the plasma concentration of HDL induced by probucol operate?].
    Med Clin (Barc); 1988 Apr; 90(13):556-7. PubMed ID: 3393042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental pharmacology of probucol (author's transl)].
    Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2981-4. PubMed ID: 7443435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HDL on the interaction of hyperlipemic LDL with monkey smooth muscle cells.
    Bates SR
    Artery; 1980; 7(4):303-15. PubMed ID: 7213019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal toxicity studies of probucol (author's transl)].
    Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3001-4. PubMed ID: 7443439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal variation of LDL and HDL cholesterol.
    Miettinen TA
    Ann Clin Res; 1980 Dec; 12(6):295-8. PubMed ID: 7195181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol and high-density-lipoprotein cholesterol.
    Gagné C; Lupien PJ; Brun D; Moorjani S; Toussaint M
    Can Med Assoc J; 1980 Sep; 123(5):356. PubMed ID: 7260778
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
    Tsujita M; Yokoyama S
    Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of probucol. II].
    Donatelli L
    Clin Ter; 1984 Mar; 108(6):475-95. PubMed ID: 6233067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of probucol on low-density lipoproteins in patients resistant to diet therapy].
    Bertolami MC; Bertolami V
    Arq Bras Cardiol; 1982 Jun; 38(6):483-7. PubMed ID: 6762869
    [No Abstract]   [Full Text] [Related]  

  • 15. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders].
    Mertz DP
    Med Klin; 1980 Feb; 75(4):159-61. PubMed ID: 7374617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
    Hong SC; Zhao SP; Wu ZH
    Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol and atherosclerosis-fact or fiction?
    Nash DT
    Geriatrics; 1981 Jan; 36(1):128-32. PubMed ID: 7450502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.